tirzepatide clinical trial results on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 Cardiovascular outcomes of semaglutide and

In Europe, the past year saw the arrival of a new weight-loss device called Reset thatwhile not explicitly authorized for use in a post-GLP-1 drug settingintroduces a sleevelike liner to the duodenum that physically prevents contact between food and the gut wall

Visceral Fat Reduction: The most dangerous fat deep abdominal visceral fat was notably reduced without changes in calorie intake

In trials, more adults taking Wegovy than placebo had an increase in resting heart rate from 1 to 4 beats per minute on average

2 Likes DrFraser May 21, 2024, 9:53pm #16 Yes Ive seen some literature on that

GLP-1s and hs-CRP: How Much Do They Lower Inflammation